journal article·2019-03-13

Enhanced Lysosomal Escape of pH-Responsive Polyethylenimine–Betaine Functionalized Carbon Nanotube for the Codelivery of Survivin Small Interfering RNA and Doxorubicin

Yue Cao, Hao-Yan Huang, Li-Qing Chen, Huan-Huan Du, Jing-Hao Cui, Leshuai W. Zhang, Beom-Jin Lee, Qing-Ri Cao

ACS Applied Materials & Interfaces· Volume 11· Issue 10
Publisher page

Abstract

The combination of gene therapy and chemotherapy has recently received considerable attention for cancer treatment. However, low transfection efficiency and poor endosomal escape of genes from nanocarriers strongly limit the success of the clinical use of small interfering RNA (siRNA). In this study, a novel pH-responsive, surface-modified single-walled carbon nanotube (SWCNT) was designed for the codelivery of doxorubicin (DOX) and survivin siRNA. Polyethylenimine (PEI) was covalently conjugated with betaine, and the resulting PEI-betaine (PB) was further synthesized with the oxidized SWCNT to form SWCNT-PB (SPB), which exhibits an excellent pH-responsive lysosomal escape of siRNA. SPB was modified with the targeting and penetrating peptide BR2 (SPBB), thereby achieving considerably higher uptake of siRNA than SWCNT-PEI (SP) or SPB. Furthermore, SPBB-siRNA presented substantially lower survivin expression and higher apoptotic index than Lipofectamine 2000. DOX and survivin siRNA were adsorbed onto SPB to form DOX-SPBB-siRNA, and siRNA/DOX was released into the cytoplasm and nuclei of adenocarcinomic human alveolar basal epithelial (A549) cells without lysosomal retention. Compared with SPBB-siRNA or DOX-SPBB treatment alone, DOX-SPBB-siRNA significantly reduced tumor volume in A549 cell-bearing nude mice, demonstrating the synergistic effects of DOX and survivin siRNA. Pathological analysis also indicated the potential therapeutic effects of DOX-SPBB-siRNA on tumors without distinct damages to normal tissues. In conclusion, the novel functionalized SWCNT loaded with DOX and survivin siRNA was successfully synthesized, and the nanocomplex exhibited effective antitumor effects both in vitro and in vivo, thereby providing an alternative strategy for the codelivery of antitumor drugs and genes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Pharmacy, Beijing Health Vocational College, Beijing 100053, People’s Republic of China

College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea

Funding

National Natural Science Foundation of China · Priority Academic Program Development of Jiangsu Higher Education Institutions · National Key Research and Development Program of China

References (41)

Show source-provided references
1. 10.5009/gnl.2013.7.4.38510.5009/gnl.2013.7.4.385 ↗
2. Kigawa J. · Yonago Acta Med. · 2013 · 56 · 43
3. 10.1021/acs.molpharmaceut.7b0109310.1021/acs.molpharmaceut.7b01093 ↗
4. 10.1093/nar/gkv30710.1093/nar/gkv307 ↗
5. 10.1093/nar/gku136210.1093/nar/gku1362 ↗
6. Nguyen T. · Curr. Opin. Mol. Ther. · 2008 · 10 · 158
7. 10.2147/IJN.S12631010.2147/IJN.S126310 ↗
8. 10.1016/j.jconrel.2017.10.02510.1016/j.jconrel.2017.10.025 ↗
9. 10.1021/bc300025d10.1021/bc300025d ↗
10. 10.1021/bm101244j10.1021/bm101244j ↗
11. 10.1016/j.actbio.2016.02.02110.1016/j.actbio.2016.02.021 ↗
12. 10.1021/bc049864q10.1021/bc049864q ↗
13. 10.1016/j.colsurfb.2013.02.04210.1016/j.colsurfb.2013.02.042 ↗
14. 10.1016/j.biomaterials.2010.09.02110.1016/j.biomaterials.2010.09.021 ↗
15. 10.1016/j.jconrel.2018.05.01210.1016/j.jconrel.2018.05.012 ↗
16. 10.1186/s13046-016-0334-y10.1186/s13046-016-0334-y ↗
17. 10.7150/thno.1685510.7150/thno.16855 ↗
18. 10.1021/bm201020h10.1021/bm201020h ↗
19. 10.1021/acsnano.6b0093610.1021/acsnano.6b00936 ↗
20. 10.1016/j.biomaterials.2011.11.00410.1016/j.biomaterials.2011.11.004 ↗
21. 10.1002/anie.20060429510.1002/anie.200604295 ↗
22. 10.1016/j.jconrel.2013.04.01810.1016/j.jconrel.2013.04.018 ↗
23. 10.1371/journal.pone.006608410.1371/journal.pone.0066084 ↗
24. 10.1021/ja010172b10.1021/ja010172b ↗
25. 10.1016/j.saa.2014.12.04110.1016/j.saa.2014.12.041 ↗
26. 10.3109/21691401.2015.101967010.3109/21691401.2015.1019670 ↗
27. 10.1016/j.biomaterials.2013.12.07910.1016/j.biomaterials.2013.12.079 ↗
28. 10.1021/bm301826m10.1021/bm301826m ↗
29. 10.1021/ci040001110.1021/ci0400011 ↗
30. 10.1021/nn700040t10.1021/nn700040t ↗
31. 10.1038/mtna.2016.1110.1038/mtna.2016.11 ↗
32. 10.1074/jbc.M116.71913810.1074/jbc.M116.719138 ↗
33. 10.1074/jbc.M20954820010.1074/jbc.M209548200 ↗
34. 10.1016/j.jconrel.2012.06.03610.1016/j.jconrel.2012.06.036 ↗
35. 10.1016/j.addr.2013.09.01210.1016/j.addr.2013.09.012 ↗
36. 10.1117/1.JBO.18.9.09600610.1117/1.JBO.18.9.096006 ↗
37. 10.1007/s13346-015-0218-210.1007/s13346-015-0218-2 ↗
38. 10.1002/chem.20110344510.1002/chem.201103445 ↗
39. 10.1016/j.colsurfb.2012.04.01310.1016/j.colsurfb.2012.04.013 ↗
40. 10.1166/jnn.2011.345410.1166/jnn.2011.3454 ↗
41. 10.1039/C4TB02073A10.1039/C4TB02073A ↗